First AD

Second AD

What is role of ven-ibr in these patient populations? 

Comparing Venetoclax-Ibrutinib, Venetoclax-Obinutuzumab, and BTKi Options

Video content above is prompted by the following:

What is role of ven-ibr in these patient populations?

When may you opt for this approach over other time-limited therapy options (ven-obi) or continuous BTKi therapy?


Video Series

OncLive Peer Exchange® 

® Peer Exchange video program comprises lively expert panel discussions feature peer-to-peer exchanges providing authoritative insights, opinions, and perspectives on important issues facing today’s health care professionals. Episodes focus on updates and insights across solid and hematologic malignancies, including breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, gynecological cancers, and hematologic malignancies. 

Chronic Lymphocytic Leukemia

 Chronic Lymphocytic Leukemia condition center page is a comprehensive resource for clinical news and expert insights on treatment advances and ongoing research in chronic lymphocytic leukemia. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs and updates with chronic lymphocytic leukemia therapy. 

Clinical

® Clinical Focus page includes a listing of all specialities covered across  OncLive.com, including breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, hematologic malignancies, and gynecologic cancers. Each individual specialty page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances in both the localized and metastatic settings, and ongoing research.


ASH 2024: Global Updates in the Management of Chronic Lymphocytic Leukemia  

Peer Exchange

Panelists discuss the role of ven-ibr in patient populations.